Every other month DMRF Canada publishes Going Forward; our bi-monthly e-newsletter.
What's Making News
The DMRF is pleased to announce the appointment of Joel S. Perlmutter, MD as Scientific Director. (Pictured with Scientific Director Emeritus, Mahlon Delong, MD.)
We’re thrilled to introduce the 2019 Chuck’s Run Ambassador, Sarah-Anne.
Last year, Sarah-Anne and her family participated in Chuck’s Run, and it was a pivotal point in Sarah’s journey with dystonia. “ To see the community come together – to know that so many people there – strangers who I didn’t know - had once been alone like me - was a feeling like no other.”
The Jackson Mooney Dystonia Patient Grant was established to provide financial assistance of up to $5,000.00 for Canadian residents who are living with dystonia, in financial need and committed to enhancing their current situation through furthering their education. You can read about Jackson Mooney's experience with dystonia here. To qualify for this grant, an individual must:
• Have been diagnosed by a medical professional as having dystonia;
November 2018: The DMRF Canada Board of Directors is pleased and proud to announce the launch of a new grant intended to fund research that could lead to better clinical treatments for dystonia patients. "DMRF Canada is committed to supporting the highest quality dystonia research in Canada," said Stefanie Ince, Executive Director.
This is the second research investment that has been announced this fall, following the launch of a two year Clinical Fellowship which was launched in October 2018.
Toronto Western General Hospital is conducting a clinical research study to test a new drug for Cervical Dystonia (abnormal spasms in the neck).
The drug is currently approved for use in the USA and Canada for treating epilepsy. The purpose of this study is to test the safety and benefit in treating the symptoms of cervical dystonia.
All participants receive the active drug.
To participate you must: